Deconstructing Metal-Organic Framework Mediated Sonodynamic Therapy for Precision Tumor Treatment

Conventional sonodynamic therapy (SDT) relies on the rapid generation of reactive oxygen species (ROS) upon ultrasound irradiation. However, the low energy density of ultrasound and the transient nature of the resulting charge excitations limit the total yield of ROS. Furthermore, the therapy-resistant tumor microenvironment (TME), characterized by severe hypoxia, elevated glutathione (GSH) levels, and a dense stromal architecture, rapidly quenches these reactive species, significantly attenuating their biological effects.

Existing strategies often focus on isolated material parameters, failing to address the systemic suppression imposed by the TME. Based on these challenges, or due to these problems, in-depth research on orchestrating robust and sustained oxidative cascades through precision-engineered nanostructures is urgently needed.

In a review (DOI: 10.1021/prechem.6c00075) available online October 13, 2026 in Precision Chemistry, researchers from the Hefei National Research Center for Physical Sciences at the Microscale, University of Science and Technology of China, detailed a mechanism-driven design framework for next-generation sonodynamic platforms. The review, authored by Jiawei Kang, Chenyang Bi, Qianwang Chen, and Dongdong Wang, systematically elucidates the intrinsic relationships among acoustic response, charge transfer, and catalytic reactions within metal-organic frameworks (MOFs). By shifting the perspective from materials optimization to reaction process programming, the team proposes a clear mechanistic landscape for constructing highly efficient sonoresponsive therapeutic systems.

The review deconstructs MOF-mediated SDT into a highly coupled three-component system: a sonic energy harvester, a signal transducer, and a catalytic reactor. First, the ultrahigh surface area and nanoporous structure of MOFs act as cavitation nuclei, lowering the energy barrier for bubble collapse. Second, these localized acoustic energies are converted into electronic responses via sonoluminescence-driven excitation and mechanically induced piezoelectric polarization. The diverse charge transfer modes within the frameworks - including ligand-to-metal charge transfer (LMCT) and metal-to-ligand charge transfer (MLCT) - dictate the separation of these charges.

Finally, the metal nodes serve as redox-active centers, catalyzing the transformation of charge carriers into specific primary reactive oxygen species, such as hydroxyl radicals (•OH) and singlet oxygen (1O2). Crucially, the ordered framework suppresses charge recombination while confined microenvironments enrich substrates. Furthermore, this dynamic network drives TME reprogramming through four interconnected cascade cycles: a Fenton amplification cycle, a redox-collapse cycle, an oxygen self-sustaining cycle, and a lipid peroxidation amplification cycle. These cascades amplify oxidative stress, alleviate hypoxia, and trigger immunogenic cell death (ICD), paving the way for synergistic combinations with immunotherapy.

The authors explained that the role of MOFs extends far beyond that of conventional sonosensitizers, encompassing broader functions such as energy transduction and microenvironment modulation. They said "future progress in this field depends on a deeper mechanistic understanding across multiple length and time scales." They emphasized that developing advanced operando characterization techniques combined with theoretical modeling will be crucial for guiding the rational design of next-generation systems. They added that "by regulating cavitation phenomena and exploring diverse energy-transduction mechanisms, researchers can achieve precise control over the entire acoustic-to-chemical energy conversion process, transforming theoretical concepts into viable clinical platforms."

This comprehensive framework holds substantial implications for the precise treatment of deep-seated and large solid tumors. By explicitly linking acoustic input, charge-carrier dynamics, and biological responses, the proposed mechanism-driven design principles enable the rational engineering of MOF-based platforms. Beyond primary tumor ablation, these precision sonoreactors can synergize with various modalities - such as photothermal therapy, starvation therapy, and immune checkpoint blockade - to eradicate metastatic lesions and establish systemic immunological memory. Moving forward, the integration of standardized acoustic dosimetry, scalable manufacturing, and rigorous assessments of biological fate will be essential to bridge the gap between laboratory research and clinical application, ultimately accelerating the translation of MOF-based SDT.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.